PREDILIFE (EPA:ALPRE) | Finanzwire

Basculer en Français

8298	Companies
114933	Keywords
55342	Articles
62466	Press releases

Home
Companies
PREDILIFE

BRIEF

published on 11/07/2024 at 18:35, 13 days 19 hours ago

Subsidiary of MammoRisk by Predilife for €202 million

MammoRisk Breast Cancer International Development Subsidiary Valorization
BRIEF

published on 10/30/2024 at 19:05, 21 days 19 hours ago

Predilife publishes its 2024 half-yearly financial report

Artificial Intelligence Financial Report Euronext Growth PREDILIFE Medical Prediction
BRIEF

published on 10/28/2024 at 08:35, 24 days 5 hours ago

PREDILIFE Half-Yearly Results and Outlook for 2024

Financial Results Strategic Partnerships Growth 2024 PREDILIFE MammoRisk®
BRIEF

published on 10/21/2024 at 18:35, 30 days 19 hours ago

The Rocher Group is committed to women's health with PREDILIFE

PREDILIFE Breast Cancer Pink October Rocher Group Health Prevention
BRIEF

published on 10/08/2024 at 08:50, 1 month 13 days ago

Predilife reaches the milestone of 1,000 registrations for its predictive assessments

PREDILIFE Pathologies MammoRisk Predictive Assessments Pink October
BRIEF

published on 10/02/2024 at 20:35, 1 month 18 days ago

Signing of the Mammorisk partial asset contribution agreement by Predilife

PREDILIFE MammoRisk Breast Cancer Subsidiary Personalized Screening
BRIEF

published on 07/19/2024 at 18:05, 4 months 1 day ago

Half-year review of the PREDILIFE liquidity contract as of June 30, 2024

Liquidity Transactions Half-yearly PREDILIFE FASD
BRIEF

published on 07/12/2024 at 19:20, 4 months 8 days ago

PREDILIFE raises funds of €775,000

Fundraising Convertible Bonds Treasury Funding PREDILIFE
BRIEF

published on 05/29/2024 at 18:35, 5 months 22 days ago

PREDILIFE STRENGTHENS ITS ASSETS WITH A NEW AI PATENT

Artificial Intelligence Patent PREDILIFE MammoRisk MyPeBS
PRESS RELEASE

published on 05/29/2024 at 18:30, 5 months 22 days ago

PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD
PREDILIFE obtains European patent for its AI breast cancer risk prediction method, reinforcing its assets. The method's strong performance and diverse applications position it as a valuable asset in the field of predictive medicine

PREDILIFE Breast Cancer Predictive Medicine European Patent AI Method

Accesswire

Published on 11/21/2024 at 14:00, 14 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 14 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 14 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 14 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report
Published on 11/21/2024 at 13:30, 44 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:00, 14 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 59 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 39 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 59 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours 8 minutes ago

IVU AG publishes Quarterly Report Q3-2024

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 16 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 54 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE